Balt said yesterday that it won CE Mark approval in the European Union for the Titan aspiration catheter. The catheter dates back to the September 2016 acquisition of endovascular device developer Blockade Medical and its Barricade coil. Blockade’s facility in Irvine, Calif., became the headquarters for Balt’s new American subsidiary, with Blockade co-founder, president & […]
Neurvana Medical alleges Balt sought to ‘sabotage and destroy’ after spinout
Neurvana Medical this month accused Balt International and a pair of its senior executives of reneging on a $16 million deal for its Titan neurovascular catheter in scheme to “sabotage and destroy” Neurvana. The story of the lawsuit, filed Jan. 17 in the Delaware Chancery Court, begins with Balt’s September 2016 acquisition of Blockade Medical, including its Barricade […]
7 medtech stories we missed this week: March 23, 2018
From Medizone’s evaluation deal to Advantis Medical Imaging getting CE Mark approval, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Medizone inks AsepticSure evaluation deal with commercial cleaning products maker Innovasource Medizone announced in a March 22 press release that it has signed a product evaluation agreement with […]
Balt International buys Blockade Medical
European medtech firm Balt International said today it acquired endovascular device developer Blockade Medical for an undisclosed amount. The acquisition is part of Balt’s ongoing strategy to bolster its neurovascular portfolio as well as efforts to develop a presence in the U.S., the company said. “This acquisition is a first strategic move towards transforming Balt […]
MassDevice Network
@MassDevice
LinkedIn
YouTube